Age, new comorbidities, inflammation, cognitive reserve, and changes in anxiety levels alter drug effects and recovery.
This study presents a valuable finding on the mutational order for common alterations in colorectal cancer. The evidence of in vitro growth assays comparing mutations is solid, although inclusion of ...